OR51F3P

Across TCGA pan-cancer cohorts, OR51F3P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated OR51F3P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher OR51F3P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR51F3P expression acts as an unfavorable survival marker.

HNSC, THCA, and CHOL are the cancer types where OR51F3P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	II,III,IV	0.177	0.727	<.001	78	view →
THCA	DFS	Tertile	III,IV	0.460	0.933	<.001	48	view →
CHOL	DFS	Tertile	All	0.045	0.486	.009	45	view →
KIRC	DFS	Tertile	IV	0.106	0.640	<.001	36	view →
BLCA	OS	Tertile	All	0.097	0.688	<.001	36	view →
LUSC	DFS	Tertile	All	0.381	0.664	.023	27	view →
SKCM	DFS	Tertile	III,IV	0.058	0.648	.001	9	view →
ESCA	OS	Tertile	All	0.516	0.720	.035	9	view →
LGG	DFS	Tertile	All	0.572	0.849	.014	6	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

OR51F3P–HNSC (OS)

Open the HNSC breakdown →